10x Genomics (TXG) Debt to Equity (2018 - 2019)
10x Genomics recorded quarterly Debt to Equity of $0.07 in Q4 2019, little changed quarter-over-quarter from $0.07 in Q3 2019, and up 152.44% year-over-year from $0.03 in Q4 2018.
10x Genomics' Debt to Equity history runs 2 years deep, the most recent figure standing at $0.07 for Q4 2019.
- In Q4 2019, Debt to Equity rose 152.44% year-over-year to $0.07; the TTM figure through Dec 2019 stood at $0.07 (up 152.44% YoY), while the FY2019 annual figure was $0.07, up 152.44% from the prior year.
- Debt to Equity came in at $0.07 for Q4 2019 at 10x Genomics, roughly flat from $0.07 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.07 in Q4 2019 to a low of -$0.13 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 1.26 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 0.46 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 0.37 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.07 |
| Sep 30, 2019 | 0.07 |
| Dec 31, 2018 | -0.13 |